PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways

Cellular Signalling

Volumn 24, Issue 3, 2012, Pages 726-733

  Park, Sung Ho ^a   Lee, Jeong Heon ^d   Lee, Gwang Beom ^c   Byun, Hyun Jung ^b   Kim, Boh Ram ^b   Park, Chan Yong ^a   Kim, Hong Bae ^a   Rho, Seung Bae ^b  

^a Hallym University   (South Korea)

^b National Cancer Center   (South Korea)

^c Gachon University   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

Author keywords

Apoptosis; Cell cycle; Cisplatin; NF B signalling; Ovarian tumorigenesis; Programmed cell death 6; Tumor suppressor protein

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 9; CASPASE 9 INHIBITOR; CISPLATIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROGRAMMED CELL DEATH 6; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVITY; FEMALE; FETUS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULTRAVIOLET IRRADIATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-BINDING PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CISPLATIN; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME ACTIVATION; FEMALE; HUMANS; NF-KAPPA B; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855585741     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.11.006     Document Type: Article

References (36)

1. Maki M., Narayana S.V., Hitomi K. Biochemical Journal 1997, 328:718-720.
2. Krebs J., Saremaslani P., Caduff R. Biochimica et Biophysica Acta 2002, 1600:68-73.
3. Vito P., Lacana E., D'Adamio L L. Science 1996, 271:521-525.
4. Jang I.K., Hu R., Lacana E., D'Adamio E.L., Gu H. Molecular and Cellular Biology 2002, 22:4094-4100.
5. Rao R.V., Poksay K.S., Castro-Obregon S., Schilling B., Row R.H., del Rio G., Gibson B.W., Ellerby H.M., Bredesen D.E. Journal of Biological Chemistry 2004, 279:177-187.
6. Mahul-Mellier A.L., Hemming F.J., Blot B., Fraboulet S., Sadoul R. The Journal of Neuroscience 2006, 26:542-549.
7. la Cour J.M., Mollerup J., Winding P., Tarabykina S., Schested M., Berchtold M.W. American Journal of Pathology 2003, 163:81-89.
8. Subramanian L., Polans A.S. Biochemical and Biophysical Research Communication 2004, 322:1153-1165.
9. Maki M., Kitaura Y., Satoh H., Ohkouchi S., Shibata H. Biochimica et Biophysica Acta 2002, 1600:51-60.
10. Yamada Y., Arao T., Gotoda T., Taniguchi H., Oda I., Shirao K., Shimada Y., Hamaguchi T., Kato K., Hamano T., Koizumi F., Tamura T., Saito D., Shimoda T., Saka M., Fukagawa T., Katai H., Sano T., Sasako M., Nishio K. Cancer Science 2008, 99:2193-2199.
11. Høj B.R., la Cour J.M., Mollerup J., Berchtold M.W. Biochemical and Biophysical Research Communication 2009, 378:145-148.
12. Jamieson E.R., Lippard S.J. Chemical Reviews 1999, 99:2467-2498.
13. Charalabopoulos K., Karkabounas S., Ioachim E., Papalimneou V., Syrigos K., Evangelou A., Agnantis N., Hadjiliadis N. European Journal of Clinical Investigation 2002, 32:129-133.
14. Covens A., Carey M., Bryson P., Verma S., Fung Kee Fung M., Johnston M. Gynecologic Oncology 2002, 85:71-80.
15. Androulakis N., Syrigos K., Polyzos A., Aravantinos G., Stathopoulos G.P., Ziras N., Mallas K., Vamvakas L., Georgoulis V. Cancer Investigation 2005, 23:9-12.
16. Polyzos A., Syrigos K., Stergiou J., Panopoulos C., Potamianou A., Vamvakas L., Georgoulias V. Cancer Chemotherapy and Pharmacology 2005, 55:466-470.
17. Androulakis N., Aravantinos G., Syrigos K., Polyzos A., Ziras N., Tselepatiotis E., Samonis G., Kentepozidis N., Giassas S., Vamvakas L., Georgoulias V. Oncology 2006, 70:280-284.
18. Karapanagiotou E.M., Boura P.G., Papamichalis G., Konstantinou M., Sepsas E., Chamalakis G., Simsiris P., Gkiozos I., Syrigos K.N. Anticancer Research 2009, 29:4297-4301.
19. Syrigos K.N., Karachalios D., Karapanagiotou E.M., Nutting C.M., Manolopoulos L., Harrington K.J., Nutting C.M., Manolopoulos L., Harrington K.J. Cancer Treatment Reviews 2009, 35:237-245.
20. Charpidou A., Tsagouli S., Tsimpoukis S., Vassias A., Makrilia N., Stratakos G., Gkiozos I., Syrigos K. Anti-Cancer Drugs 2010, 21:651-655.
21. Lee J.H., Rho S.B., Chun T. Biotechnology Letters 2005, 27:1011-1015.
22. Hanahan D., Weinberg R.A. Cell 2000, 100:57-70.
23. Pommier Y., Sordet O., Antony S., Hayward R.L., Kohn K.W. Oncogene 2004, 23:2934-2949.
24. la Cour J.M., Høj B.R., Mollerup J., Simon R., Sauter G., Berchtold M.W. Molecular Oncology 2008, 1:431-439.
25. Muggia E. Gynecologic Oncology 2009, 112:275-281.
26. Moore D.H., Tian C., Monk B.J., Long H.J., Omura G.A., Bloss J.D. Gynecologic Oncology 2010, 116:44-49.
27. Kelland L. Nature Reviews Cancer 2007, 7:573-584.
28. Lustberg M.B., Edelman M.J. Current Treatment Options in Oncology 2007, 8:38-46.
29. Gallagher D.J., Milowsky M.I. Current Treatment Options in Oncology 2009, 10:205-215.
30. Yang E.S., Murphy B.M., Chung C.H., Netterville J.L., Burkey B.B., Gilbert J J., Yarbrough W.G., Sinard R., Cmelak A.J. Critical Reviews in Oncology/Hematology 2009, 71:29-42.
31. Hussain S.A., Ma Y.T., Cullen M.H. Expert Review of Anticancer Therapy 2008, 8:771-784.
32. Mandruzzato S., Brasseur F., Andry G., Boon T., van der Bruggen P. The Journal of Experimental Medicine 1997, 186:785-793.
33. Kim T.J., Rho S.B., Choi Y.L., Choi C.H., Lee J.W., Bae D.S., Ahn G., Lee J.H., Kim B.G. Human Pathology 2006, 37:906-913.
34. Mistry P., Kelland L.R., Abel G., Sidhar S., Harrap K.R. British Journal of Cancer 1991, 64:215-220.
35. Kim H.S., Lee J.W., Soung Y.H., Park W.S., Kim S.Y., Lee J.H., Park J.Y., Cho Y.G., Kim C.J., Jeong S.W., Nam S.W., Kim S.H., Lee J.Y., Yoo N.J., Lee S.H. Gastroenterology 2003, 125:708-715.
36. Molly P.L. Methods in Molecular Biology 2000, 130:235-246.